Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations

The Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) was a 12-month, Phase III, open-label, randomised study comparing the effectiveness and safety of initiating once-daily fluticasone furoate 100 µg/vilanterol 25 µg (FF/VI) with continuing usual care (UC). Follow-up interviews...

Descripción completa

Detalles Bibliográficos
Autores principales: Whalley, Diane, Svedsater, Henrik, Doward, Lynda, Crawford, Rebecca, Leather, David, Lay-Flurrie, James, Bosanquet, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509249/
https://www.ncbi.nlm.nih.gov/pubmed/31073124
http://dx.doi.org/10.1038/s41533-019-0123-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509249/
https://www.ncbi.nlm.nih.gov/pubmed/31073124
http://dx.doi.org/10.1038/s41533-019-0123-0

Ejemplares similares